[1]
I. Nawaiseh, A. Halawa, and D. Alardah, “Intravitreal ranibizumab in the management of acute central serous Chorioretinopathy”, Int J Clin Exp Ophthalmol, vol. 1, no. 1, pp. 049–054, Nov. 2017.